Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I have a scenario

i think this is the most realistic.

TPL buying out ptsc...reserve merger to become a public company..... investors can either cash out their shares or hold on and be shareholders of TPL....

dreams just dreams...maybe one day....  otherwise   go PTSC  lol 

 

Share
New Message
Please login to post a reply